DaBomb Protein Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	322.83	309.34	337.82	384.41	433.63	470.63
Revenue Growth (YoY)	5.76%	-8.43%	-12.12%	-11.35%	-7.86%	-22.24%
Cost of Revenue	250.85	240.3	269.1	337.99	414.3	448.98
Gross Profit	71.98	69.04	68.73	46.43	19.33	21.65
Selling, General & Admin	83.2	80.99	55.6	62.77	69.95	73.61
Research & Development	15.98	16.23	14.95	13.59	11.85	11.82
Operating Expenses	99.18	97.22	70.55	76.36	81.8	85.42
Operating Income	-27.2	-28.18	-1.82	-29.93	-62.47	-63.77
Interest Expense	-2.49	-3.07	-5.21	-8.23	-6.58	-4.58
Interest & Investment Income	1.54	1.8	5.02	6.33	2.37	2.44
Currency Exchange Gain (Loss)	0.52	0.52	14.89	-0.82	15.68	-6.86
Other Non Operating Income (Expenses)	4.07	3.19	3.17	2.36	1.87	1.15
EBT Excluding Unusual Items	-23.57	-25.75	16.05	-30.29	-49.13	-71.62
Gain (Loss) on Sale of Investments	0.22	0.22	-0.02	-0.07	-	-
Gain (Loss) on Sale of Assets	-0.16	-0.16	0.04	-25.59	0.05	-
Asset Writedown	-40.65	-40.65	-	-	-	-
Other Unusual Items	0	0	-	-	0.03	-
Pretax Income	-64.16	-66.34	16.07	-55.95	-49.06	-71.62
Income Tax Expense	1.73	3	4.43	1.08	-4.39	-9.17
Net Income	-65.89	-69.34	11.64	-57.03	-44.66	-62.45
Net Income to Common	-65.89	-69.34	11.64	-57.03	-44.66	-62.45
Shares Outstanding (Basic)	72	72	67	54	39	32
Shares Outstanding (Diluted)	72	72	72	54	39	32
Shares Change (YoY)	0.08%	0.11%	34.30%	38.27%	19.16%	-0.13%
EPS (Basic)	-0.92	-0.96	0.17	-1.07	-1.15	-1.92
EPS (Diluted)	-0.92	-0.96	0.17	-1.07	-1.15	-1.92
Free Cash Flow	-3.67	-21.04	17.32	-12.37	-0.29	-376.35
Free Cash Flow Per Share	-0.05	-0.29	0.24	-0.23	-0.01	-11.59
Dividend Per Share	-	-	0.170	0.550	1.000	-
Dividend Growth	-	-	-69.09%	-45.00%	-	-
Gross Margin	22.30%	22.32%	20.34%	12.08%	4.46%	4.60%
Operating Margin	-8.43%	-9.11%	-0.54%	-7.79%	-14.41%	-13.55%
Profit Margin	-20.41%	-22.41%	3.45%	-14.83%	-10.30%	-13.27%
Free Cash Flow Margin	-1.14%	-6.80%	5.13%	-3.22%	-0.07%	-79.97%
EBITDA	14.65	10.5	10.44	-9.98	-37.48	-39.81
EBITDA Margin	4.54%	3.39%	3.09%	-2.60%	-8.64%	-8.46%
D&A For EBITDA	41.85	38.68	12.27	19.95	25	23.96
EBIT	-27.2	-28.18	-1.82	-29.93	-62.47	-63.77
EBIT Margin	-8.43%	-9.11%	-0.54%	-7.79%	-14.41%	-13.55%
Effective Tax Rate	-	-	27.57%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.